JAZZ

STRONG BUY

Jazz Pharmaceuticals plc

Health Care

0.09

PEGY ratio

Rank #10

Why This Matters

This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 10000.0% annually over 5 years.

JAZZ is trading at 2063.3x earnings against 22265.0% growth (no dividend), giving a PEGY of 0.09. The math suggests the stock is significantly undervalued relative to its growth and income profile.

~ Growth estimate uses historical CAGR (forward estimates unavailable)

• Growth rate derived from historical CAGR — limited analyst coverage.

Scan date: 2026-05-08

Valuation

2063.3x

P/E Ratio

Growth

10000.0%

5yr EPS

Income

0.0%

Div Yield

PEGY Components

PEGY Score0.09

Denominator10000.0%

EPS (TTM)$0.11

Market Data

Price$226.96

ExchangeNASDAQ

S&P 500

What Changed

Zone

Invalid→Strong Buy

vs 7 days ago

Portfolio Context

Founder does not hold this stock.

Not in your portfolio.

Sector: Health Care

PEGY History — 90 days

I Want to Invest Not Right Now

Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only